Chitosan derivatives as nanocarriers for hLDHA inhibitors delivery to hepatic cells: A selective strategy for targeting primary hyperoxaluria diseases

1. Salido, S.
2. Alejo-Armijo, A.
3. Parola, A.J.
4. Sebastián, V.
5. Alejo, T.
6. Irusta, S.
7. Arruebo, M.
8. Altarejos, J.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1016/J.IJPHARM.2022.122224 GOOGLE SCHOLAR lock_openOpen access editor